Presence of large, hyperlobated and/or hyperchromatic megakaryocytes should prompt evaluation of the presence of JAK2, CALR or MPL mutations by NGS or PCR, as PMF may coexist with SM as an associated hematological neoplasm (SM-AHN) [49]. Here, MPL is linked to systemic mastocytosis.